Somatostatin Receptor Type 2 Antagonism (SSTR2a) Augments Glucagon Counterregulation and Delays Hypoglycemia Onset in Type 2 Diabetic (T2D), Sprague-Dawley Rats

被引：0
作者：
Hoffman, Emily G.
Dsouza, Ninoschka
Aiken, Julian
Liggins, Richard
Riddell, Michael
机构：
来源：
DIABETES | 2021年 / 70卷
关键词：
D O I：
10.2337/db21-133-OR
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
133-OR
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Glucagon like peptide-1 gene delivery increases beta cell replication and neogenesis in Type 2 Diabetic Obese Sprague Dawley Rats
    Tasyurek, H. M.
    Altunbas, H. A.
    Sanlioglu, S.
    HUMAN GENE THERAPY, 2016, 27 (11) : A156 - A156
  • [42] Cardiovascular (CV) and Hypoglycemia Outcomes across Age Groups in People with Type 2 Diabetes (T2D) in the CAROLINA Trial
    Espeland, Mark
    Pratley, Richard E.
    Rosenstock, Julio
    Kadowaki, Takashi
    Seino, Yutaka
    Zinman, Bernard
    Marx, Nikolaus
    Mcguire, Darren K.
    Andersen, Knut R.
    Mattheus, Michaela
    Keller, Annett
    Johansen, Odd Erik
    DIABETES, 2020, 69
  • [43] Effect of the GLP-1 Receptor Agonist Lixisenatide on Glucagon Counterregulation to Hypoglycemia in Subjects with Insulin-Treated Type 2 Diabetes
    Ahren, Bo
    Farngren, Johan
    Persson, Margaretha
    DIABETES, 2015, 64 : A283 - A283
  • [44] Glucagon responses to exercise-induced hypoglycaemia are improved by somatostatin receptor type 2 antagonism in a rat model of diabetes
    Erwan Leclair
    Richard T. Liggins
    Ashley J. Peckett
    Trevor Teich
    David H. Coy
    Mladen Vranic
    Michael C. Riddell
    Diabetologia, 2016, 59 : 1724 - 1731
  • [45] Glucagon responses to exercise-induced hypoglycaemia are improved by somatostatin receptor type 2 antagonism in a rat model of diabetes
    Leclair, Erwan
    Liggins, Richard T.
    Peckett, Ashley J.
    Teich, Trevor
    Coy, David H.
    Vranic, Mladen
    Riddell, Michael C.
    DIABETOLOGIA, 2016, 59 (08) : 1724 - 1731
  • [46] Response to therapy in children with different phenotypic presentations of new-onset type 2 diabetes (T2D)
    Ryabets-Lienhard, A
    Ball, G
    Shaibi, G
    Cruz, M
    Kobaissi, H
    Goran, M
    Weigensberg, M
    OBESITY RESEARCH, 2004, 12 : A52 - A52
  • [47] Cytokines, Chemokines, Insulin and Haematological Indices in Type 2 Diabetic Male Sprague Dawley Rats Infected with Trichinella zimbabwensis
    Silas, Ekuyikeno
    Tshilwane, Selaelo Ivy
    Mukaratirwa, Samson
    APPLIED SCIENCES-BASEL, 2022, 12 (15):
  • [48] Advancing Therapy in Uncontrolled Basal Insulin-Treated Type 2 Diabetes (T2D): Nocturnal Hypoglycemia in the SoliMix Trial
    Mccrimmon, Rory J.
    Cheng, Alice Y.
    Fonseca, Vivian
    Choza, Ricardo
    Alessa, Thamer
    Alvarez, Agustina
    Souhami, Elisabeth
    Boss, Anders H.
    Picard, Pascaline
    Rosenstock, Julio
    DIABETES, 2021, 70
  • [49] Effects of somatostatin receptor type 2 antagonism during insulin-induced hypoglycaemia in male rats with prediabetes
    Hoffman, Emily G.
    D'Souza, Ninoschka C.
    Aiken, Julian
    Atherley, Sara
    Liggins, Richard
    Riddell, Michael C.
    DIABETES OBESITY & METABOLISM, 2023, 25 (06) : 1547 - 1556
  • [50] Understanding the Pathophysiology of Youth-Onset Type 2 Diabetes (T2D): Importance of Alpha-Cell Function
    Lat, Jessica
    Caprio, Sonia
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (09) : E3957 - E3958
12345